|
|
Article: Celgene Corporation Reports Record Third Quarter Revenue and Operating Profits.
- Article from:
- PR Newswire
- Article date:
- October 26, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Product Sales Drive Record Third Quarter Revenue and Profits:
* Record Net Product Sales of $223.1 Million
- REVLIMID Achieved $101.3 Million in Net Product Sales
- THALOMID Net Product Sales Totaled $108.4 Million
* Record Adjusted Net Income of $59.4 Million with Adjusted Diluted Earnings Per Share of $0.15
Financial Highlights of Third Quarter Performance Year-Over-Year:
* Total Revenue Increased 89.1% to a Record $244.8 Million